Search Results | Diabetes Care | American Diabetes Association

1-20 of 170

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

Diabetes Care dc220607

DOI: https://doi.org/10.2337/dc22-0607

Published: 25 May 2022

View article

Journal Articles

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes

Bruce A. Perkins, Ionut Bebu, Xiaoyu Gao, Amy B. Karger, Irl B. Hirsch, Harsha Karanchi, Mark E. Molitch, Bernard Zinman, John M. Lachin, Ian H. de Boer

Diabetes Care 2022;45(3):585–593

DOI: https://doi.org/10.2337/dc21-1883

Published: 11 January 2022

View article

Journal Articles

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee

Diabetes Care 2022;45(Supplement_1):S175–S184

DOI: https://doi.org/10.2337/dc22-S011

Published: 16 December 2021

View article

Journal Articles

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Diabetes Care 2021;44(8):1805–1815

DOI: https://doi.org/10.2337/dc21-0076

Published: 11 August 2021

View article

Journal Articles

Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations

Nikita Stempniewicz, Joseph A. Vassalotti, John K. Cuddeback, Elizabeth Ciemins, Amy Storfer-Isser, Yingying Sang, Kunihiro Matsushita, Shoshana H. Ballew, Alex R. Chang, Andrew S. Levey, Robert A. Bailey, Jesse Fishman, Josef Coresh

Diabetes Care 2021;44(9):2000–2009

DOI: https://doi.org/10.2337/dc20-2715

Published: 07 July 2021

View article

Journal Articles

Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes

Rose Gubitosi-Klug, Xiaoyu Gao, Rodica Pop-Busui, Ian H. de Boer, Neill White, Lloyd P. Aiello, Ryan Miller, Jerry Palmer, William Tamborlane, Amisha Wallia, Mikhail Kosiborod, John M. Lachin, Ionut Bebu, the DCCT/EDIC Research Group

Diabetes Care 2021;44(7):1499–1505

DOI: https://doi.org/10.2337/dc20-3104

Published: 12 May 2021

View article

Journal Articles

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Frederik Persson, Stephen C. Bain, Ofri Mosenzon, Hiddo J.L. Heerspink, Johannes F.E. Mann, Richard Pratley, Itamar Raz, Thomas Idorn, Søren Rasmussen, Bernt Johan von Scholten, Peter Rossing

Diabetes Care 2021;44(4):1020–1026

DOI: https://doi.org/10.2337/dc20-1622

Published: 27 January 2021

View article

Journal Articles

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes

Michael Fang, Elizabeth Selvin

Diabetes Care 2021;44(3):699–706

DOI: https://doi.org/10.2337/dc20-2304

Published: 08 January 2021

View article

Journal Articles

Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

Maryam Saeed, German Tapia, Inger Ariansen, Lars C. Stene, Ingebjørg Seljeflot, Grethe S. Tell, Torild Skrivarhaug, Geir Joner

Diabetes Care 2021;44(3):810–816

DOI: https://doi.org/10.2337/dc20-1712

Published: 06 January 2021

View article

Journal Articles

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43: 2760–2767

Katsuhito Ihara, Jan Skupien, Hiroki Kobayashi, Zaipul I. Md Dom, Jonathan M. Wilson, Kristina O’Neil, Hannah S. Badger, Lenden M. Bowsman, Eiichiro Satake, Matthew D. Breyer, Kevin L. Duffin, Andrzej S. Krolewski

Diabetes Care 2021;44(2):631

DOI: https://doi.org/10.2337/dc21-er02

Published: 17 December 2020

View article

Journal Articles

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021

American Diabetes Association

Diabetes Care 2021;44(Supplement_1):S151–S167

DOI: https://doi.org/10.2337/dc21-S011

Published: 04 December 2020

View article

Journal Articles

Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study

James L. Januzzi, Jr., Javed Butler, Naveed Sattar, Jialin Xu, Wayne Shaw, Norman Rosenthal, Michael Pfeifer, Kenneth W. Mahaffey, Bruce Neal, Michael K. Hansen

Diabetes Care 2021;44(1):210–216

DOI: https://doi.org/10.2337/dc20-1889

Published: 06 November 2020

View article

Journal Articles

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Vlado Perkovic, Robert Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Bernard Zinman, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Maximillian von Eynatten, Jyothis T. George, Odd Erik Johansen, Christoph Wanner

Diabetes Care 2020;43(8):1803–1812

DOI: https://doi.org/10.2337/dc20-0279

Published: 22 May 2020

View article

Journal Articles

Reduced Myocardial Perfusion Reserve in Type 2 Diabetes Is Caused by Increased Perfusion at Rest and Decreased Maximal Perfusion During Stress

Martin H. Sørensen, Annemie S. Bojer, Julie R.N. Pontoppidan, David A. Broadbent, Sven Plein, Per L. Madsen, Peter Gæde

Diabetes Care 2020;43(6):1285–1292

DOI: https://doi.org/10.2337/dc19-2172

Published: 19 March 2020

View article

Journal Articles

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

Karin Littmann, Tigist Wodaje, Michael Alvarsson, Matteo Bottai, Mats Eriksson, Paolo Parini, Jonas Brinck

Diabetes Care 2020;43(8):1851–1858

DOI: https://doi.org/10.2337/dc19-1398

Published: 20 December 2019

View article

Journal Articles

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020

American Diabetes Association

Diabetes Care 2020;43(Supplement_1):S135–S151

DOI: https://doi.org/10.2337/dc20-S011

Published: 16 December 2019

View article

Journal Articles

Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Oyunchimeg Buyadaa, Dianna J. Magliano, Agus Salim, Digsu N. Koye, Jonathan E. Shaw

Diabetes Care 2020;43(1):122–129

DOI: https://doi.org/10.2337/dc19-1438

Published: 03 December 2019

View article

Includes: Supplementary data

Journal Articles

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakuboniene, Brian Katona, Yuliya Lokhnygina, Renato D. Lopes, Aldo P. Maggioni, Peter Ohman, Tsvetalina Tankova, George L. Bakris, Adrian F. Hernandez, Rury R. Holman

Diabetes Care 2020;43(2):446–452

DOI: https://doi.org/10.2337/dc19-1065

Published: 22 November 2019

View article

Includes: Supplementary data

Journal Articles

Progression of Diabetic Kidney Disease in the Absence of Albuminuria

Richard J. MacIsaac, Elif I. Ekinci

Diabetes Care 2019;42(10):1842–1844

DOI: https://doi.org/10.2337/dci19-0030

Published: 12 September 2019

View article

Journal Articles

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

Daniël H. van Raalte, Petter Bjornstad, Frederik Persson, David R. Powell, Rita de Cassia Castro, Ping Stella Wang, Minzhi Liu, Hiddo J.L. Heerspink, David Cherney

Diabetes Care 2019;42(10):1921–1929

DOI: https://doi.org/10.2337/dc19-0937

Published: 01 August 2019

View article

Includes: Supplementary data

2 3 4 5

NARROW

Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes

11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations

Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes

Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43: 2760–2767

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021

Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Reduced Myocardial Perfusion Reserve in Type 2 Diabetes Is Caused by Increased Perfusion at Rest and Decreased Maximal Perfusion During Stress

The Association of Lipoprotein(a) Plasma Levels With Prevalence of Cardiovascular Disease and Metabolic Control Status in Patients With Type 1 Diabetes

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020

Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

Progression of Diabetic Kidney Disease in the Absence of Albuminuria

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only